Luca Falzone
Cited by
Cited by
Evolution of cancer pharmacological treatments at the turn of the third millennium
L Falzone, S Salomone, M Libra
Frontiers in pharmacology 9, 1300, 2018
Cutaneous melanoma: From pathogenesis to therapy
GC Leonardi, L Falzone, R Salemi, A Zanghì, DA Spandidos, ...
International journal of oncology 52 (4), 1071-1080, 2018
Gut microbiota and cancer: from pathogenesis to therapy
S Vivarelli, R Salemi, S Candido, L Falzone, M Santagati, S Stefani, ...
Cancers 11 (1), 38, 2019
Current and future trends on diagnosis and prognosis of glioblastoma: from molecular biology to proteomics
AS Silantyev, L Falzone, M Libra, OI Gurina, KS Kardashova, ...
Cells 8 (8), 863, 2019
Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection
L Falzone, N Musso, G Gattuso, D Bongiorno, CI Palermo, G Scalia, ...
International journal of molecular medicine 46 (3), 957-964, 2020
Current perspectives in cancer immunotherapy
T Christofi, S Baritaki, L Falzone, M Libra, A Zaravinos
Cancers 11 (10), 1472, 2019
SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19
A Tsatsakis, D Calina, L Falzone, D Petrakis, R Mitrut, V Siokas, M Pennisi, ...
Food and Chemical Toxicology 146, 111769, 2020
Integrated analysis of colorectal cancer microRNA datasets: Identification of microRNAs associated with tumor development
L Falzone, L Scola, A Zanghì, A Biondi, A Di Cataldo, M Libra, S Candido
Aging (Albany NY) 10 (5), 1000, 2018
Current and innovative methods for the diagnosis of COVID‑19 infection
L Falzone, G Gattuso, A Tsatsakis, DA Spandidos, M Libra
International journal of molecular medicine 47 (6), 1-23, 2021
SARS-CoV-2 and the nervous system: from clinical features to molecular mechanisms
M Pennisi, G Lanza, L Falzone, F Fisicaro, R Ferri, R Bella
International Journal of Molecular Sciences 21 (15), 5475, 2020
Occupational exposure to carcinogens: Benzene, pesticides and fibers
L Falzone, A Marconi, C Loreto, S Franco, DA Spandidos, M Libra
Molecular medicine reports 14 (5), 4467-4474, 2016
Immunological effects of occupational exposure to lead
C Fenga, S Gangemi, V Di Salvatore, L Falzone, M Libra
Molecular medicine reports 15 (5), 3355-3360, 2017
Lactobacillus rhamnosus GG: An Overview to Explore the Rationale of Its Use in Cancer
GL Banna, F Torino, F Marletta, M Santagati, R Salemi, E Cannarozzo, ...
Frontiers in pharmacology 8, 603, 2017
Identification of novel MicroRNAs and their diagnostic and prognostic significance in oral cancer
L Falzone, G Lupo, GRM La Rosa, S Crimi, CD Anfuso, R Salemi, ...
Cancers 11 (5), 610, 2019
Cutaneous melanoma and the immunotherapy revolution
GC Leonardi, S Candido, L Falzone, DA Spandidos, M Libra
International journal of oncology 57 (3), 609-618, 2020
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
JA McCubrey, TL Fitzgerald, LV Yang, K Lertpiriyapong, LS Steelman, ...
Oncotarget 8 (8), 14221, 2017
Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluid
R Battaglia, S Palini, ME Vento, A La Ferlita, MJ Lo Faro, E Caroppo, ...
Scientific reports 9 (1), 84, 2019
Prognostic significance of deregulated microRNAs in uveal melanomas
L Falzone, GL Romano, R Salemi, C Bucolo, B Tomasello, G Lupo, ...
Molecular medicine reports 19 (4), 2599-2610, 2019
Functional roles of matrix metalloproteinases and their inhibitors in melanoma
S Napoli, C Scuderi, G Gattuso, V Di Bella, S Candido, MS Basile, M Libra, ...
Cells 9 (5), 1151, 2020
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer
L Falzone, S Candido, R Salemi, MS Basile, A Scalisi, JA McCubrey, ...
Oncotarget 7 (45), 72758, 2016
The system can't perform the operation now. Try again later.
Articles 1–20